series-b
Stage
2005
Founded
1
Investors
About
MedDay Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for neurological disorders, notably investigating high-dose biotin (MD1003) for progressive multiple sclerosis.
Explore MedDay Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.